Published in J Hepatol on October 23, 2011
Molecular virology in transfusion medicine laboratory. Blood Transfus (2012) 0.79
Report of a patient with complex composites of hepatitis B virus, allergic asthma and diabetes. Asian Pac J Trop Biomed (2014) 0.75
Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol (2008) 3.50
Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion (2005) 3.08
The DELLA domain of GA INSENSITIVE mediates the interaction with the GA INSENSITIVE DWARF1A gibberellin receptor of Arabidopsis. Plant Cell (2007) 2.60
The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med (2009) 2.06
Transfusion-transmitted hepatitis B virus infection. J Hepatol (2009) 1.70
Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med (2011) 1.69
The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood (2002) 1.66
The impact of model assumptions on results of computational mechanics in abdominal aortic aneurysm. J Vasc Surg (2010) 1.61
Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J Virol (2003) 1.50
Infectivity of blood products from donors with occult hepatitis B virus infection. Transfusion (2013) 1.43
Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol (2004) 1.43
Persistence of HTLV-I in blood components after leukocyte depletion. Blood (2002) 1.39
Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood (2005) 1.39
Blood donor screening for parvovirus B19 in Germany and Austria. Transfusion (2007) 1.35
Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1. J Virol Methods (2004) 1.33
Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol (2008) 1.30
Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J Gen Virol (2007) 1.28
Micro- and nanomechanical analysis of articular cartilage by indentation-type atomic force microscopy: validation with a gel-microfiber composite. Biophys J (2010) 1.26
Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J Hepatol (2008) 1.25
Maternofetal transmission of hepatitis B virus genotype E in Ghana, west Africa. J Gen Virol (2007) 1.23
Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection. Hepatology (2010) 1.23
Dating the origin and dispersal of hepatitis B virus infection in humans and primates. Hepatology (2013) 1.19
Sensitivity of HCV RNA and HIV RNA blood screening assays. Transfusion (2002) 1.15
Localization of uroplakin Ia, the urothelial receptor for bacterial adhesin FimH, on the six inner domains of the 16 nm urothelial plaque particle. J Mol Biol (2002) 1.14
Diagnostic algorithm for HBV safe transfusion. Blood Transfus (2009) 1.08
Transfusion in sub-Saharan Africa: does a Western model fit? J Clin Pathol (2007) 1.06
Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Hepatology (2006) 1.04
Hepatitis C virus and hepatitis B virus bind to heparin: purification of largely IgG-free virions from infected plasma by heparin chromatography. J Gen Virol (2005) 1.03
HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells. AIDS (2009) 1.03
Simultaneous visual detection of multiple viral amplicons by dipstick assay. J Clin Microbiol (2005) 1.02
Molecular characterization of occult hepatitis B virus in genotype E-infected subjects. J Gen Virol (2008) 1.01
Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain. Transfusion (2009) 1.00
Molecular epidemiology of HIV in Ghana: dominance of CRF02_AG. J Med Virol (2004) 1.00
Protective effect of HLA-B57 on HCV genotype 2 infection in a West African population. J Med Virol (2007) 1.00
Full genome characterization of hepatitis B virus strains from blood donors in Iran. J Med Virol (2011) 1.00
Characterization of periplasmic protein BP26 epitopes of Brucella melitensis reacting with murine monoclonal and sheep antibodies. PLoS One (2012) 1.00
Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus Type 1 in blood donors. Transfusion (2013) 0.99
Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence. Gut (2012) 0.99
Characterization of occult hepatitis B virus strains in South African blood donors. Hepatology (2009) 0.99
A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol (2009) 0.98
External financial aid to blood transfusion services in sub-Saharan Africa: a need for reflection. PLoS Med (2012) 0.98
A cluster of human immunodeficiency virus Type 1 recombinant form escaping detection by commercial genomic amplification assays. Transfusion (2010) 0.97
Investigating native coronary artery endothelium in situ and in cell culture by scanning force microscopy. J Struct Biol (2005) 0.97
Multiplex real-time PCR for the detection and quantification of latent and persistent viral genomes in cellular or plasma blood fractions. J Virol Methods (2008) 0.97
Evaluation of a new hepatitis B virus surface antigen rapid test with improved sensitivity. J Clin Microbiol (2008) 0.96
Unusual wetting dynamics of aqueous surfactant solutions on polymer surfaces. J Colloid Interface Sci (2003) 0.96
Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection. Clin Infect Dis (2011) 0.95
Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus? Swiss Med Wkly (2008) 0.94
A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period. Transfusion (2008) 0.94
Fiducial marker-based correction for involuntary motion in weight-bearing C-arm CT scanning of knees. Part I. Numerical model-based optimization. Med Phys (2013) 0.93
Prevalence of persistent and latent viruses in untreated patients infected with HIV-1 from Ghana, West Africa. J Med Virol (2009) 0.93
Nucleic acid testing (NAT) in high prevalence-low resource settings. Biologicals (2010) 0.93
Duplex molecular assay intended for point-of-care diagnosis of influenza A/B virus infection. J Clin Microbiol (2013) 0.92
The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan. Transfusion (2009) 0.92
Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan. J Clin Microbiol (2010) 0.89
Investigating the prevalence of transfusion transmission of Plasmodium within a hyperendemic blood donation system. Transfusion (2012) 0.89
Antibody detection and kinetics of antibody production during early stages of immunization with hepatitis B virus vaccine. Clin Vaccine Immunol (2007) 0.89
Characterization of occult hepatitis B virus infection from blood donors in China. J Clin Microbiol (2011) 0.89
Differential reactivity of putative genotype 2 hepatitis C virus F protein between chronic and recovered infections. J Gen Virol (2008) 0.89
Hepatitis B virus in transfusion medicine: still a problem? Biologicals (2012) 0.88
Deletions and recombinations in the core region of hepatitis B virus genotype E strains from asymptomatic blood donors in Guinea, west Africa. J Gen Virol (2009) 0.87
Nucleic acid dipstick test for molecular diagnosis of pandemic H1N1. J Clin Microbiol (2010) 0.87
Comparison of seven hepatitis B virus (HBV) nucleic acid testing assays in selected samples with discrepant HBV marker results from United States blood donors. Transfusion (2014) 0.86
Influence of chronic hypoxia and radiation quality on cell survival. J Radiat Res (2013) 0.86
Higher viral load may explain the dominance of CRF02_AG in the molecular epidemiology of HIV in Ghana. AIDS (2004) 0.86
Recombinant interferon-γ lentivirus co-infection inhibits adenovirus replication ex vivo. PLoS One (2012) 0.86
Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area. Transfusion (2006) 0.85
Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic. J Clin Microbiol (2006) 0.85
Can family or replacement blood donors become regular volunteer donors? Transfusion (2013) 0.84
Infection of common marmosets with hepatitis C virus/GB virus-B chimeras. Hepatology (2014) 0.84
Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion-transmitted hepatitis B virus infection in Switzerland, a low-endemic region. Transfusion (2010) 0.84
Multi-dimensional flow-preserving compressed sensing (MuFloCoS) for time-resolved velocity-encoded phase contrast MRI. IEEE Trans Med Imaging (2014) 0.84
Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system. Transfusion (2003) 0.83
Infection frequency of hepatitis C virus and IL28B haplotypes in Papua New Guinea, Fiji, and Kiribati. PLoS One (2013) 0.83
Use of hydrodynamic forces to engineer cartilaginous tissues resembling the non-uniform structure and function of meniscus. Biomaterials (2006) 0.83
Evaluation of speech intelligibility for children with cleft lip and palate by means of automatic speech recognition. Int J Pediatr Otorhinolaryngol (2006) 0.82
Using Smartphones to Monitor Bipolar Disorder Symptoms: A Pilot Study. JMIR Ment Health (2016) 0.82
Hepatitis B virus DNA splicing in Lebanese blood donors and genotype A to E strains: implications for hepatitis B virus DNA quantification and infectivity. J Clin Microbiol (2012) 0.82
Plasmodium genome in blood donors at risk for malaria after several years of residence in Italy. Transfusion (2014) 0.82
Approximate truncation robust computed tomography--ATRACT. Phys Med Biol (2013) 0.82
Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors. Transfusion (2005) 0.82
Towards clinical application of a Laplace operator-based region of interest reconstruction algorithm in C-arm CT. IEEE Trans Med Imaging (2014) 0.82